These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36410986)

  • 1. Gene Expression Profiles in Cutaneous Oncology.
    Kitrell BM; Blue ED; Siller A; Lobl MB; Evans TD; Whitley MJ; Wysong A
    Dermatol Clin; 2023 Jan; 41(1):89-99. PubMed ID: 36410986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma.
    Amaral TMS; Hoffmann MC; Sinnberg T; Niessner H; Sülberg H; Eigentler TK; Garbe C
    Eur J Cancer; 2020 Jan; 125():38-45. PubMed ID: 31838403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test.
    Ibrahim SF; Kasprzak JM; Hall MA; Fitzgerald AL; Siegel JJ; Kurley SJ; Covington KR; Goldberg MS; Farberg AS; Trotter SC; Reed K; Brodland DG; Koyfman SA; Somani AK; Arron ST; Wysong A
    Future Oncol; 2022 Mar; 18(7):833-847. PubMed ID: 34821148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic variables in high-risk cutaneous squamous cell carcinoma: a review.
    Cheng J; Yan S
    J Cutan Pathol; 2016 Nov; 43(11):994-1004. PubMed ID: 27404896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
    Hooper PB; Farberg AS; Fitzgerald AL; Siegel JJ; Rackley BB; Prasai A; Kurley SJ; Goldberg MS; Litchman GH
    Cancer Invest; 2022 Nov; 40(10):911-922. PubMed ID: 36073945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.
    Li H; Pedersen L; Nørgaard M; Ulrichsen SP; Thygesen SK; Nelson JJ
    BMC Cancer; 2016 May; 16():295. PubMed ID: 27141983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
    Burton KA; Ashack KA; Khachemoune A
    Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults.
    Ferrante di Ruffano L; Dinnes J; Chuchu N; Bayliss SE; Takwoingi Y; Davenport C; Matin RN; O'Sullivan C; Roskell D; Deeks JJ; Williams HC;
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013187. PubMed ID: 30521689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
    Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
    Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face.
    Feller L; Khammissa RAG; Kramer B; Altini M; Lemmer J
    Head Face Med; 2016 Feb; 12():11. PubMed ID: 26850723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma.
    Litchman GH; Fitzgerald AL; Kurley SJ; Cook RW; Rigel DS
    Curr Med Res Opin; 2020 Aug; 36(8):1295-1300. PubMed ID: 32372702
    [No Abstract]   [Full Text] [Related]  

  • 12. Seven key hub genes identified by gene co-expression network in cutaneous squamous cell carcinoma.
    Chen H; Yang J; Wu W
    BMC Cancer; 2021 Jul; 21(1):852. PubMed ID: 34301206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
    Nguyen AH; Detty SQ; Agrawal DK
    Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
    Griewank KG; Murali R; Schilling B; Schimming T; Möller I; Moll I; Schwamborn M; Sucker A; Zimmer L; Schadendorf D; Hillen U
    PLoS One; 2013; 8(11):e80354. PubMed ID: 24260374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of clinical outcomes for patients diagnosed with skin cancer spinal metastases.
    Goodwin CR; Sankey EW; Liu A; Elder BD; Kosztowski T; Lo SF; Fisher CG; Clarke MJ; Gokaslan ZL; Sciubba DM
    J Neurosurg Spine; 2016 May; 24(5):837-49. PubMed ID: 26544595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: impact on patient management.
    Farberg AS; Hall MA; Douglas L; Covington KR; Kurley SJ; Cook RW; Dinehart SM
    Curr Med Res Opin; 2020 Aug; 36(8):1301-1307. PubMed ID: 32351136
    [No Abstract]   [Full Text] [Related]  

  • 17. The microRNA landscape of cutaneous squamous cell carcinoma.
    Konicke K; López-Luna A; Muñoz-Carrillo JL; Servín-González LS; Flores-de la Torre A; Olasz E; Lazarova Z
    Drug Discov Today; 2018 Apr; 23(4):864-870. PubMed ID: 29317340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.
    García-Sancha N; Corchado-Cobos R; Pérez-Losada J; Cañueto J
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients.
    Borman S; Wilkinson J; Meldi-Sholl L; Johnson C; Carter K; Covington KR; Fitzgerald AL; Kurley SJ; Farberg AS; Goldberg MS; Monzon FA; Oelschlager K; Cook RW
    Diagn Pathol; 2022 Feb; 17(1):32. PubMed ID: 35216597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and new perspectives in the treatment of advanced cutaneous squamous cell carcinoma.
    Brancaccio G; Moscarella E; Briatico G; Verolino P; Alfano R; Argenziano G
    Minerva Med; 2020 Dec; 111(6):589-600. PubMed ID: 32955822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.